Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2001, 21(21):8482-8494
The Nonuniform Distribution of the GABAA Receptor
1 Subunit Influences Inhibitory Synaptic Transmission to Motoneurons
within a Motor Nucleus
Jennifer A.
O'Brien and
Albert J.
Berger
Department of Physiology and Biophysics, University of Washington,
Seattle, Washington 98195-7290
 |
ABSTRACT |
Using immunohistochemistry we studied the distribution of
GABAA and glycine receptor
1 subunits in the rat
hypoglossal nucleus during postnatal development. In the neonate
[postnatal day (P) 1-3] and adult nucleus (P28-30),
GABAA receptor
1 subunit labeling was relatively modest.
However, in the juvenile nucleus (P9-13), labeling was strong in the
ventrolateral region and moderate in the dorsal region. Glycine
receptor
1 subunit labeling was strong and uniform in the juvenile
and adult nucleus and absent in the neonate nucleus. GABA and glycine
neurotransmitter labeling was uniform throughout the neonatal and
juvenile nucleus. To study the functional consequences of this regional
differential GABAA receptor
1 subunit distribution, we
voltage clamped juvenile hypoglossal motoneurons (HMs) from the
ventrolateral and dorsal regions and recorded spontaneous miniature
IPSCs (mIPSCs). Pure GABAergic events had slower decay times
than glycinergic events. Although pure GABAergic and glycinergic decay
times did not differ depending on HM location, the decays of mixed
mIPSCs from ventrolateral HMs, recorded without GABAA and
glycine receptor antagonists, had significantly slower decays than
mIPSCs from dorsal HMs. Focally applied GABA and glycine onto
outside-out patches revealed that the GABAergic to glycinergic peak
current amplitude ratio was larger for patches from ventrolateral HMs
compared with dorsal HMs. Dual component mIPSCs, presumably caused by
co-release of GABA and glycine, were recorded more frequently in the
ventrolateral nucleus. These data suggest that the number of synapses
using GABAA receptor-mediated transmission is greater on
ventrolateral HMs than dorsal HMs, demonstrating a nonuniformity of
synaptic function within a defined motor nucleus.
Key words:
glycine receptor; glycine; GABA; synaptic transmission; immunohistochemistry; GABAA receptor; inhibition; hypoglossal motoneurons; hypoglossal nucleus; dorsal motor nucleus of
vagus; brainstem
 |
INTRODUCTION |
GABA and glycine are the two main
inhibitory neurotransmitters in the CNS, each activating a different
family of ligand-gated ion channels. Although GABA is the main
inhibitory neurotransmitter in the brain, both GABA and glycine can
contribute to inhibition of single neurons in the brainstem and spinal
cord (Jonas et al., 1998
; O'Brien and Berger, 1999
). In the developing
spinal cord and brainstem, the overall contribution of each
neurotransmitter to total inhibition of neurons can change (Gao and
Ziskind-Conhaim, 1995
; Kotak et al., 1998
). Specifically during
development, the amounts of GABA or glycine expressed (Simon and
Horcholle-Bossavit, 1999
) and changes in the inhibitory postsynaptic
receptor density, distribution, and subunit composition can occur
(Fritschy et al., 1994
; Kotak et al., 1998
; Singer et al., 1998
).
Hypoglossal motoneurons (HMs) are located in the brainstem and
innervate the tongue, which is involved in several motor functions, including mastication, swallowing, sucking, and speech (Lowe, 1980
). It
is also important for respiration, because it has a critical position
in the upper airway. HMs are inhibited by both GABA and glycine
in vivo (Altmann et al., 1972
; Takata and Ogata, 1980
).
Experiments have shown that activation of orofacial afferents evoke
glycinergic and GABAergic currents in HMs, suggesting that these
currents have important functions associated with activation of
orofacial sensory inputs (Sumi, 1969
; Sumino and Nakamura, 1974
). Several airway-related diseases may involve alterations in function of these motoneurons, including sleep apnea and sudden infant death syndrome (Konrat et al., 1992
). Studies in humans have
suggested that increased glycinergic inhibitory synaptic transmission
to HMs may be a contributing factor in obstructive sleep apnea during
REM sleep (Remmers et al., 1980
; Yamuy et al., 1999
). Thus
understanding inhibition to HMs may lead to a better understanding of airway-related diseases.
At the cellular level, in neonatal rats GABA and glycine are
co-released onto HMs from the same presynaptic terminal (O'Brien and
Berger, 1999
). Studies of glycine receptor-mediated synaptic transmission during the first few weeks of development have
demonstrated a subunit switch of this receptor leading to a decrease in
the miniature IPSC (mIPSC) decay times (Singer et al., 1998
). Also, during development there is an increase in the number of glycine receptors at each synapse, leading to an increase in the mIPSC response
amplitude (Singer and Berger, 1999
). Changes in the expression of the
GABAA and glycine receptors may influence the
effect of these inhibitory neurotransmitters and thereby influence
motor output throughout the first weeks of postnatal development.
Therefore, we used immunohistochemistry and electrophysiology to study
in HMs the relative contributions of GABAergic and glycinergic
inhibitory synaptic transmission, and we primarily focused on the
intermediate stage of postnatal development [postnatal day (P)
9-13]. Our results suggest that at this age the relative contribution
of GABAA receptor-mediated synaptic transmission
varied throughout the hypoglossal nucleus.
 |
MATERIALS AND METHODS |
Primary antibodies. To study the distribution of the
GABAA receptors in the hypoglossal nucleus, we
used an antibody directed against the first 15 amino acids of the rat
GABAA receptor
1 subunit (Upstate
Biotechnology, Lake Placid, NY) (Vitorica et al., 1990
). Two different
aliquots of this antibody were used at the following dilutions: 1:750
and 1:75. To study the glycine receptor distribution, we used a
monoclonal (mouse) antibody directed against the first 10 amino acids
of the rat glycine receptor
1 subunit (Alexis Corporation, San
Diego, CA) at a dilution of 1:100 (Pfeiffer et al., 1984
). To study the
distribution of choline acetyltransferase (ChAT) in the hypoglossal
nucleus, we used a monoclonal antibody at a dilution of 1:100
(Chemicon, Temecula, CA) (Crawford et al., 1982
). The distribution of
GABA and glycine neurotransmitter was studied using polyclonal
antibodies to GABA and glycine at dilutions of 1:750 and 1:2000,
respectively (gift from D. Pow; University of Queensland, Australia)
(Pow et al., 1995
).
Immunohistochemistry. For all immunohistochemical
experiments, Sprague Dawley rats were anesthetized by injection
(intramuscular) of a ketamine-xylazine mixture (200 and 14 mg/kg,
respectively). Rats were separated into three age groups: P1-3
(neonatal), P9-13 (juvenile), and P28-30 (adult). After decapitation,
the brainstems were removed.
For double-label studies of the GABAA receptor
1 subunit and the glycine receptor
1 subunit, brainstems were
frozen on dry ice. Transverse brainstem sections were cut using a
cryostat (20-30 µm thick). Tissues were then fixed in 4%
paraformaldehyde (Ted Pella, Redding, CA) in PBS for 10-20 min. The
slide-mounted tissue sections were then incubated in PBS blocking
solution containing 0.2% Triton X-100 (Sigma, St. Louis, MO) and 10%
donkey serum (Vector Laboratories, Burlingame, CA) for 1 hr at room
temperature. Slices were placed overnight in a PBS blocking solution
containing the primary antibodies at 4°C. After washing in PBS,
tissue sections were incubated in secondary antibodies Cy3-conjugated
anti-rabbit IgG (1:600; Jackson ImmunoResearch Laboratories, West
Grove, PA) and biotin-SP-conjugated anti-mouse IgG (1:200; Jackson
ImmunoResearch Laboratories) in PBS blocking solution for 90 min at
room temperature. After washing, tissue sections were incubated in
Fluorescein Avidin D (1:500; Vector Laboratories) for 60 min at room
temperature. The slides were then coverslipped with Vectashield (Vector Laboratories).
For single-label studies of GABA and glycine neurotransmitter, as well
as double-label studies of GABAA receptor
1
subunit and ChAT, transverse brainstem slices were cut using a
vibratome (300-700 µm thick). During slicing, the brainstems were
immersed in an ice-cold Ringer's solution containing (in
mM): 119 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 2.5 KCl, 11 glucose, 2.5 CaCl2, and 1.4 MgSO4 bubbled with 95%
O2/5% CO2 gas mixture.
These sections were fixed in 4% paraformaldehyde in PBS for 1-3 d.
After fixation, slices were cryoprotected by suspending them overnight
in a PBS solution containing 30% sucrose at 4°C overnight. The
slices were then resectioned on a freezing microtome (40-50 µm thick).
Free-floating tissue sections were made permeable and blocked in PBS
blocking solution for 1 hr at room temperature. Overnight incubation
with the primary antibodies was performed in PBS blocking solution at
4°C. For single-label studies of GABA and glycine, tissues were
incubated with the secondary antibody (1:600 Cy3-conjugated anti-rabbit
IgG; Jackson ImmunoResearch Laboratories) in PBS blocking solution for
90 min at room temperature. For the double-label studies of the
GABAA receptor
1 subunit and ChAT, after
incubation in the primary antibodies the tissue sections were incubated
with Alexa Fluor 488 goat anti-rabbit IgG (1:200; Molecular Probes, Eugene, OR) and Alexa Fluor 568 anti-mouse IgG (1:200; Molecular Probes) in PBS blocking solution for 1 hr at room temperature. Sections
were then placed on slides and coverslipped with Vectashield.
Immunohistochemistry on recorded neurons. In a number of
electrophysiological experiments, a single neuron in each slice was filled with 0.1-0.5% Lucifer yellow (Sigma) or Alexa Fluor 488 (100-250 µM; Molecular Probes). After
recordings, slices were fixed overnight in 4% paraformaldehyde in PBS.
Slices (300 µm thick) were placed in 30% sucrose and then
resectioned using a freezing microtome (75 µm thick). The
free-floating slice containing the filled neuron was incubated in 0.2%
Triton X-100 and 10% donkey serum for 1 hr at room temperature,
followed by overnight incubation with GABAA
receptor
1 subunit antibody at 4°C. After washing, slices were
incubated in the secondary antibody Cy3-conjugated anti-rabbit IgG
(1:600) in PBS blocking solution for 90 min at room temperature. After
washing, slides were coverslipped with Vectashield.
Confocal microscopy. Confocal sections were collected using
either a Bio-Rad MRC-600 (Bio-Rad, Hercules, CA) or a Leica Spectral (Leica, Wetzlar, Germany) confocal microscope. For labeling with Cy3 or
Alexa Fluor 568, images were obtained using 548 nm excitation wavelength. For Fluorescein and Alexa Fluor 488 labeling, images were
obtained with 488 excitation wavelength. Images were Kalman filtered.
Using PhotoShop 5.5 (Adobe, San Jose, CA), images were cropped, sized,
and merged. Final figures were created in PowerPoint (Microsoft,
Seattle, WA).
Electrophysiology. Sprague Dawley rats, separated into two
age groups [neonatal (P1-3) and juvenile (P9-13)], were
anesthetized by injection (intramuscular) of a ketamine-xylazine
mixture (200 and 14 mg/kg, respectively). Rats were decapitated,
brainstems were removed, and transverse brainstem slices (250-300
µm) were prepared using a vibratome. During slicing, incubation (1 hr
at 37°C), and recording, the slices were bathed in a Ringer's
solution containing (in mM): 119 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 2.5 KCl, 11 glucose, 2.5 CaCl2, and 1.4 MgSO4. Solutions were bubbled continuously with
95% O2/5% CO2 gas
mixture. Using near-infrared DIC optics, HMs were identified on
the basis of their characteristic location and morphology (Umemiya and
Berger, 1994
).
Whole-cell patch-clamp and outside-out patch recordings were performed
at room temperature. Patch electrodes (resistance 1-5 M
) were
filled with (in mM): 145 CsCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2 ATP-Mg, 0.2 GTP-Tris, pH 7.2. For mIPSC
experiments, HMs were voltage clamped at
55 to
65 mV. Access
resistance was uncompensated and always <20 M
and was monitored
throughout the experiment. Data were filtered at 2 kHz and digitized at
5 kHz using pCLAMP software (Axon Instruments, Foster City, CA). To
test for the selectivity of bicuculline and strychnine, glycine (200 µM) and GABA (200 µM) were applied (10-50
msec) using a dual-channel Picospritzer (General Valve, Fairfield, NJ)
and a single-barrel glass pipette (World Precision Instruments,
Sarasota, FL). For measurements of the responses, five current traces
were averaged, and peak current amplitude was measured using pCLAMP
6.0, 7.0, or 8.0 software (Axon Instruments). These experiments were
performed in the presence of tetrodotoxin (TTX; 0.5-1
µM) and 6,7-dinitroquinoxaline (DNQX; 10-20
µM) to block
Na+-dependent action potentials and
non-NMDA glutamate receptors, respectively.
For outside-out patch recordings, a double-barrel pipette was used to
focally apply for 3 sec glycine (200 µM) or GABA (200 µM) onto excised patches. Patches were voltage clamped at
30 mV during application of glycine and GABA. These experiments were performed in the presence of TTX (0.5-1 µM) and DNQX
(10-20 µM). For comparison of data within an experiment,
all patches were excised from the same slice so that glycine and GABA
could be applied using only one double-barrel puffer pipette. The
puffer pipette was visualized and kept secure in one location so that multiple patches from a single slice could be aligned with the puffer
pipette in the same way for application of glycine and GABA.
Glycinergic mIPSCs were recorded in the presence of TTX (1 µM), DNQX (20 µM),
D(
)-2-amino-5 phosphopentanoic acid (AP5; 25-50 µM), and bicuculline (5 µM). GABAergic
mIPSCs were recorded in the presence of the same blockers, except that
bicuculline was replaced with strychnine (1 µM). We
measured the mIPSC peak amplitude, the time it took for mIPSC to decay
to 37% of its peak amplitude, and the 10-90% rise time of the mIPSC.
Spontaneous mIPSCs were analyzed by software developed in our
laboratory that detects events using an algorithm described by Cochran
(1993)
. A minimum of 100 events were analyzed for each neuron. Decay
times were measured as the time for the mIPSC to decay to 37% of its
peak amplitude. Results are presented as mean ± SEM unless noted
otherwise. The Kolmogorov-Smirnov statistical test was used to assess
differences in mIPSC data. An unpaired t test was used to
assess differences in mean values from different conditions. Changes
were considered significant if p < 0.05. Data plotted
as histograms were fitted with Gaussian curves using SigmaPlot (SPSS,
Chicago, IL).
The drugs that were used included bicuculline methiodide (Sigma),
strychnine hydrochloride (Sigma), TTX (Alomone Labs, Jerusalem, Israel), DNQX (RBI, Natick, MA), AP5 (RBI), and sodium pentobarbital (Abbott Labs, North Chicago, IL).
 |
RESULTS |
Distribution of GABAA
1 and glycine
1 receptor
subunits in the developing hypoglossal nucleus
To better understand the developmental progression of
GABAA receptors in the hypoglossal nucleus, we
studied changes in the
1 GABAA receptor
subunit throughout postnatal development. We used an antibody that
recognized the
1 subunit of the GABAA
receptor, because immunohistochemical studies have shown that in adult
HMs
1,
2, and
2 are the main subunits expressed, whereas
2/3,
3,
5, and
6 expression was reported to be absent
(Fritschy and Mohler, 1995
). A recent immunohistochemical study of the
neonatal hypoglossal nucleus (P1-5) found that
2 subunit staining
was present, whereas
1 staining was reported to be absent (Donato and Nistri, 2000
).
We found that GABAA receptor
1 subunit
staining in the neonatal (P1-3) hypoglossal nucleus was weak
throughout the caudal and rostral extent of the nucleus (Fig.
1A,
XII). The dorsal motor nucleus of vagus stained
moderately for the GABAA receptor
1 subunit
(Fig. 1A, X). In the juvenile
(P9-13) hypoglossal nucleus, the degree of GABAA
receptor
1 subunit staining depended on location throughout the
nucleus (Fig. 1B, XII).
Specifically throughout the caudal to middle regions of the hypoglossal
nucleus, the GABAA receptor
1 subunit staining
was strongest in the ventrolateral region (Fig. 1B,
arrow). In contrast, throughout the entire caudal to rostral
extent of the nucleus, weak to moderate staining was seen in the
dorsal and ventromedial regions. Additionally, at this postnatal age
the dorsal motor nucleus of the vagus had strong staining (Fig.
1B, X). In the adult hypoglossal
nucleus (P25-30), the GABAA receptor staining
was weak throughout its entire caudal and rostral extent, and
strong staining was seen in the dorsal motor nucleus of the vagus (Fig.
1C).

View larger version (96K):
[in this window]
[in a new window]
|
Figure 1.
Labeling of the hypoglossal nucleus for the
GABAA receptor 1 subunit in neonate (P2), juvenile
(P11), and adult (P30) rat. A, In the neonate,
GABAA receptor 1 subunit labeling was weak throughout
the hypoglossal nucleus (XII) and moderate in the
dorsal motor nucleus of the vagus (X)
(n = 4). B, In the juvenile,
GABAA receptor 1 subunit labeling was strongest in the
ventrolateral region of the hypoglossal nucleus (arrow)
and dorsal motor nucleus of the vagus, moderate in the dorsal region of
the hypoglossal, and weakest in the ventromedial region of the
hypoglossal nucleus (n = 5). C, In
the adult, GABAA receptor 1 subunit staining is modest
in the hypoglossal nucleus and strong in the dorsal motor nucleus of
the vagus (n = 5). Scale bar, 200 µm.
|
|
To study glycine receptor expression, we used an antibody that detected
the
1 subunit of the glycine receptor. Previous in situ
hybridization experiments from our laboratory demonstrated that the
glycine receptor
1 subunit is expressed in juvenile but absent in
neonate HMs, whereas the
2 subunit is expressed in neonate but
absent in juvenile HMs. In contrast, the
subunit is expressed
uniformly throughout postnatal development (Singer et al., 1998
). To
better understand the development of the glycine receptor
1 subunit,
we studied its expression throughout the postnatal period.
In neonatal animals (P1-3), very little glycine receptor
1 subunit
staining was seen in the hypoglossal or dorsal motor nucleus of the
vagus (Fig. 2A)
(n = 4). However, in the juvenile (P9-13) and adult
(P28-30) age groups, antibodies to the
1 subunit labeled the
hypoglossal nucleus uniformly, whereas staining was virtually absent in
the dorsal motor nucleus of the vagus (Fig.
2B,C) (n
4 for
each group). These data show that compared with the neonate hypoglossal
nucleus, the glycine receptor
1 subunit is uniformly present at
increased levels throughout the juvenile and adult nucleus, thus
agreeing with the previous study from our laboratory using in
situ hybridization (Singer et al., 1998
).

View larger version (84K):
[in this window]
[in a new window]
|
Figure 2.
Labeling of the hypoglossal nucleus for the
glycine receptor 1 subunit in neonate (P2), juvenile (P11), and
adult (P30) rat. A, In the glycine receptor 1
subunit, labeling is faint and diffuse throughout the hypoglossal
nucleus (XII) and dorsal motor nucleus of vagus
(X). B, C, In both the
juvenile and adult, glycine receptor 1 subunit labeling is strong
throughout the entire hypoglossal nucleus (XII)
and virtually absent from the dorsal motor nucleus of the vagus
(X). Scale bar, 200 µm.
|
|
Next we studied colocalization of the GABAA and
glycine receptor
1 subunits in the juvenile hypoglossal nucleus by
performing double labeling. GABAA receptor
1
subunit labeling (Fig. 3A, red) and glycine receptor
1 subunit labeling (Fig.
3B, green) from the same tissue section are shown
as a merged image in Figure 3C. At higher magnification of
the ventrolateral region, colocalization of the
GABAA and glycine receptor
1 subunits is
present (Fig. 3D, orange). In the dorsal and
ventromedial areas of the nucleus, double labeling of the two receptors
types was not obvious because of the weaker staining of
GABAA receptor
1 subunit as opposed to the
stronger glycine receptor
1 subunit staining. Double labeling of the
neonate and adult hypoglossal nucleus was also performed; however,
because of weak labeling of the GABAA receptor
1 subunit at these ages, colocalization of the two receptor types
was not apparent (data not shown) (n
4 for all
groups).

View larger version (73K):
[in this window]
[in a new window]
|
Figure 3.
A, B, Staining for
the GABAA receptor 1 subunit (A,
red) and glycine receptor 1 subunit
(B, green) in the same tissue section of
the hypoglossal nucleus (XII) from a juvenile
rat. C, Images from A and
B are shown merged. GABAA receptor 1
subunit labeling differs depending on location within the hypoglossal
nucleus, whereas glycine receptor labeling is uniform throughout the
nucleus. There is dense GABAA receptor 1 subunit
labeling of the ventrolateral region of the hypoglossal nucleus.
D, At higher magnification, colocalization of
GABAA and glycine receptor 1 subunits was seen
(orange). Tissues shown are from the same animal (P10)
and are representative of data obtained from five different animals.
Scale bar: A-C, 200 µm;
D, 100 µm.
|
|
To confirm that the differential GABAA receptor
1 subunit staining was present within the hypoglossal nucleus on
juvenile HMs, we labeled HMs with choline acetyltransferase (Fig.
4A1, ChAT) to identify motoneurons. Double labeling of
GABAA receptor
1 subunit and ChAT showed that
GABAA receptor
1 subunit labeling was present
on HMs in the ventrolateral region of the hypoglossal nucleus (Fig.
4A3,B1). At this high power of resolution,
each of the neuronal somata labeled with ChAT was surrounded with
GABAA receptor
1 subunit labeling. These data
indicated that some of the GABAA receptor
staining in this region was probably directly on HMs. In contrast,
GABAA receptor
1 subunit labeling in the ventromedial and dorsal regions of the hypoglossal nucleus was less
intense (Fig. 4B2,B3). HMs in these
regions were not surrounded by the dense staining observed in the
ventrolateral region. These differences in GABAA
receptor
1 subunit labeling were found in all five hypoglossal
nuclei double labeled with ChAT and GABAA receptor
1 subunit antibodies.

View larger version (158K):
[in this window]
[in a new window]
|
Figure 4.
Double labeling of the hypoglossal nucleus for the
GABAA receptor 1 subunit and ChAT in a juvenile (P10)
rat. A1, ChAT labeling of neurons in the hypoglossal and
dorsal motor nucleus of vagus. A2, GABAA
receptor 1 subunit labeling is strongest in the ventrolateral region
of the hypoglossal motor nucleus and dorsal motor nucleus of the vagus
and weakest in the dorsal region of the hypoglossal and the
ventromedial region of the hypoglossal nucleus (n = 5). A3, Double label of GABAA receptor 1
subunit (green) and ChAT (red) in
the hypoglossal nucleus. Scale bar, 200 µm.
B1-B3, Higher magnification of the
hypoglossal nucleus from the regions denoted with
asterisks. At higher magnification, GABAA
receptor 1 subunit labeling on HMs was greatest in the ventrolateral
region (B1), whereas in the ventromedial and dorsal
regions, labeling was much less intense (B2 and
B3, respectively). Scale bar, 40 µm. These
distributions were representative of all juvenile animals studied
(n = 5).
|
|
Distribution of GABA and glycine neurotransmitters in the
hypoglossal motor nucleus
We studied the distribution of glycine and GABA neurotransmitter
using antibodies that recognized the neurotransmitters. In the neonate
(P1-3) and juvenile (P9-13), GABA staining was present uniformly throughout the hypoglossal nucleus (Fig.
5A1,A2,
XII). This pattern of staining was also present in
adult HMs (P25-30; data not shown). Glycine staining was also present
uniformly throughout the hypoglossal motor nucleus (Fig.
5B1,B2, XII). These uniform distributions were seen throughout the caudal to rostral extent of the
nucleus and were also present in adult HMs (P25-30; data not shown).
Interestingly, the dorsal motor nucleus of the vagus exhibited staining
for GABA in both age groups (Fig. 5A1,A2,
X) but absent to weak glycine staining in both age
groups (Fig. 5B1,B2, X).

View larger version (111K):
[in this window]
[in a new window]
|
Figure 5.
Antibody labeling for GABA and glycine
in neonate (P2) and juvenile (P11) rat
hypoglossal nuclei. A1, In the neonate GABA labeling was
present to a similar degree in both the hypoglossal nucleus and the
dorsal motor nucleus of the vagus (n = 3).
A2, In the juvenile there was moderate uniform labeling
of the hypoglossal nucleus and uniform but denser labeling of the
dorsal motor nucleus of the vagus (n = 5).
B1, B2, In the neonate
(B1) and juvenile (B2), glycine labeling
is dense and uniform throughout the hypoglossal nucleus
(n = 3 for neonates and n = 5 for juvenile). In contrast, at both ages studied the dorsal motor
nucleus of the vagus is labeled weakly by the glycine antibody. Scale
bar, 200 µm.
|
|
Glycinergic and GABAergic responses of juvenile rats
We next studied the inhibitory properties of juvenile HMs recorded
from different regions of the hypoglossal nucleus. We focused on this
age because the staining for GABAA receptor
1
subunit varied within the nucleus at this age group in contrast to
other ages studied. We were interested in comparing the relative
contribution of GABA and/or glycine to inhibitory synaptic transmission
throughout different regions of the juvenile nucleus.
We compared GABAA and glycine receptor-mediated
synaptic responses by recording spontaneous mIPSCs in different
regions of the nucleus. Recorded spontaneous mIPSCs are caused by
release of single vesicles of neurotransmitter from presynaptic
terminals (Katz, 1969
; Isaacson and Walmsley, 1995
). Properties of
mIPSCs, including the amplitude, rise times, and decay times, often
depend on the density and type of postsynaptic receptors present at the synapse. In a previous study of neonatal HMs, we recorded both GABAA receptor-mediated mIPSCs and glycine
receptor-mediated mIPSCs (O'Brien and Berger, 1999
). The
GABAergic mIPSCs had significantly slower decay times than the
glycinergic mIPSCs. The distinct kinetics of the
GABAA and glycine receptor-mediated responses
allowed us to record dual component mIPSCs that were mediated by both
receptor subtypes in the neonate. If these findings were also present
in juvenile HMs, it would be possible to record and compare the
GABAA and glycine receptor contribution to mIPSCs
in single HMs. Specifically, mIPSCs mediated by synapses with a larger
ratio of GABAA receptors to glycine receptors
at each synapse would, on average, have relatively slower decay times
than mIPSCs mediated by synapses with a smaller ratio of
GABAA receptors to glycinergic receptors.
However, for this prediction to be true, we must also demonstrate that
the properties of isolated GABAA
receptor-mediated mIPSCs as well as glycine receptor-mediated mIPSCs
did not differ in the different regions of the hypoglossal nucleus.
Before recording isolated GABAergic and glycinergic mIPSCs, we
established the concentration of GABAA receptor
antagonist (bicuculline) and glycine receptor antagonist (strychnine)
that selectively isolate GABAA or glycine
receptor-mediated responses in juvenile HMs. To do this we focally
applied GABA and glycine onto an HM, and then bicuculline or strychnine
were bath applied. In all cells from juvenile rats, focal application
of GABA or glycine produced a current
(Vh =
60 mV; data not shown). Bath application of 5 µM bicuculline blocked 87 ± 11.6% (mean ± SD) of the GABAA
receptor-mediated current (n = 4), whereas it blocked only 7 ± 5.0% of the glycine receptor-mediated current
(n = 3). Bath application of 1 µM strychnine blocked 91 ± 5.0% of the
glycine receptor-mediated current (n = 3), whereas it
inhibited the GABAA receptor-mediated current by
only 17 ± 9.7% (n = 3). These data show that 5 µM bicuculline can selectively block the
majority of GABAA receptor-mediated responses,
without having a large effect on the glycine receptor-mediated
responses. These data also show that 1 µM
strychnine can selectively block the majority of the glycine
receptor-mediated response, without largely inhibiting GABAA receptor-mediated response.
We next studied the GABAA and glycine
receptor-mediated synaptic responses in tissue from juvenile animals.
Pure GABAergic and glycinergic mIPSCs were each recorded in isolation.
We measured the mIPSC peak amplitude, the time it took for mIPSC to
decay to 37% of its peak amplitude, and the 10-90% rise time of the mIPSC. These data are summarized in Table
1. On average, the GABAA receptor-mediated current decay times were
significantly slower than the glycinergic mIPSCs. Average GABAergic
and glycinergic decay times were 19.5 ± 7.3 msec
(n = 13) and 6.9 ± 3.3 msec (n = 13), respectively (mean ± SD; p < 0.005).
To further enhance the differences in GABAergic and glycinergic decay
times, we recorded mIPSCs in the presence of pentobarbital (25 µM). Previously we showed in neonatal HMs that
GABAA receptor-mediated mIPSCs recorded in the
presence of pentobarbital have significantly longer decay times than
glycine receptor-mediated mIPSCs (O'Brien and Berger, 1999
). In
juvenile HMs we found that pentobarbital significantly slowed the decay
kinetics of GABAergic mIPSCs in the juvenile HMs, whereas it had no
significant effect on the decay kinetics of glycine receptor-mediated
events (Table 1).
Inhibitory currents properties depend on location of
hypoglossal motoneurons
Next, we recorded mIPSCs from HMs in identified regions of the
hypoglossal nucleus of juvenile rats. During recordings, HMs were
filled with a fluorescent dye to confirm the regions within the
hypoglossal nucleus from which the recordings were made. After fixation, tissue was stained with the GABAA
receptor
1 subunit antibody (Fig.
6A1,A2).
These recordings were performed in the presence of pentobarbital (25 µM), TTX, and glutamate receptor blockers but
in the absence of strychnine and bicuculline. Therefore, mIPSCs
recorded under these conditions were caused by release of GABA and/or
glycine at different synapses on the recorded HM.

View larger version (92K):
[in this window]
[in a new window]
|
Figure 6.
Mixed mIPSCs recorded from HMs located in the
ventrolateral region have slower decay times than mIPSCs from HMs
located in the dorsal region of the hypoglossal nucleus.
A1, A2, Two slices are shown, each with a
single HM labeled with Lucifer yellow during mIPSC recordings
(gray arrows). After recordings, these sections
were labeled with antibody that recognized GABAA receptor
1 subunit. The HM in A1 is located in the dorsal region of the
hypoglossal nucleus, and the HM in A2 is located in the ventrolateral
region of the nucleus. Scale bar, 200 µm. B1,
B2, Histogram distributions of mixed mIPSC decay times
for the HMs shown in A1 and A2,
respectively. The decay times of the mIPSCs of the ventrolateral HM
(B2) were significantly slower than the decay times of
mIPSCs of the dorsal HM (B1). Inset,
Average mIPSC normalized to the peak amplitude from the ventrolateral
HM and the dorsal HM. Calibration: 100 msec.
|
|
Figure 6B shows the histogram distributions of the
decay kinetics of the two HMs pictured in Figure 6A.
The mIPSC decay kinetics of the HM from the ventrolateral region, where
GABAA receptor staining is greatest (Fig.
6A2), was slower than the decay kinetics of the HM
from the dorsal region, where GABAA receptor
1
subunit staining was less (Fig. 6A1). The mIPSC decay
time distributions from the dorsal region was significantly different
from the distribution from the ventrolateral region
(Kolmogorov-Smirnov test; p < 0.05). The average
decay time for the HM from the dorsal region was 21.5 ± 29.7 msec
(mean ± SD) (Fig. 6B1). In contrast, the
average decay time for the cell shown in the ventrolateral region was
28.7 ± 24.6 msec (Fig. 6B2). Also shown in
Figure 6B1 (inset) are averages of mIPSCs
from each of the recorded HMs shown. The averaged mIPSCs were
normalized to the peak response to better illustrate the differences in
decay kinetics for these two HMs.
We consistently found that the average decay kinetics of mIPSCs, in
the absence or presence of pentobarbital, was slower in HMs
recorded from the ventrolateral region as compared with HMs from the
dorsal region (Fig. 7A).
Plotted in Figure 7A (right panel) is the
average cumulative probability distribution of decay kinetics for
mIPSCs recorded from dorsal and ventrolateral HMs, in the presence of
pentobarbital. For each neuron studied, we also averaged the decay
times of the individual events studied. These averaged values were then
combined to obtain an average of all neurons studied (Fig.
7A, left panel). In the presence of
pentobarbital, the mean decay times were 30.7 ± 1.5 msec
(mean ± SEM; n = 8) and 19.4 ± 1.3 msec
(n = 4) in HMs from the ventrolateral and dorsal
region, respectively. These means were significantly different
(p < 0.005; t test). Additionally,
we found for mixed mIPSCs recorded without pentobarbital that the decay
kinetics were 16.0 ± 1.6 msec (n = 7) and
11.0 ± 1.2 msec (n = 6) in ventrolateral and
dorsal HMs, respectively (mean ± SEM). These values were
significantly different (p < 0.05).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 7.
GABAergic/glycinergic mixed mIPSC decay
times are slower in HMs from the ventrolateral region of the
hypoglossal nucleus as compared with the dorsal region. In contrast,
isolated GABAergic mIPSC decay times are similar in HMs from
ventrolateral and dorsal regions. Also, isolated glycinergic mIPSCs
decay times were similar in different HMs from the two regions of the
nucleus. A, Left, Bar chart of the
average mixed mIPSC decay times (±SEM) versus region. The average
decay time was greater in the ventrolateral region. Regional
differences in decay times were significant (t test;
*p < 0.05). Right, Averaged
cumulative probability (±SEM) of GABAergic and glycinergic mIPSC decay
times recorded in HMs from either the dorsal ( ) or ventrolateral
( ) hypoglossal nucleus with pentobarbital (25 µM)
present in the extracellular solution. Decay times of HMs in the
ventrolateral region are shifted to the right, compared
with those recorded in the dorsal region, indicating that a greater
percentage of mIPSCs have slower decay kinetics. B, Pure
GABAergic mIPSCs recorded in isolation (in the presence of strychnine).
Left, The average pure GABAergic mIPSC decay times were
not significantly different from HMs recorded in both regions
(n > 4 for each group; t test;
p > 0.05). Right, Cumulative
probability of GABAergic decay times from the dorsal ( ) or
ventrolateral ( ) regions overlapped. Average values ± SEM are
shown. C, Left, Pure glycinergic mIPSCs
recorded in isolation (in the presence of bicuculline) on average were
not significantly different. Right, Averaged cumulative
probability of glycinergic mIPSC decay times from the dorsal ( ) or
ventral regions ( ) overlapped.
|
|
GABAergic and glycinergic responses recorded
in isolation
Although we predicted that differences in decay times were caused
by differences in the ratio of GABAergic to glycinergic receptors at a
synapse, we needed to confirm that pure GABAA
receptor-mediated events as well as pure glycine receptor-mediated
events were the same in each region. In both cases we found on average
that the isolated GABAergic and the isolated glycinergic response
characteristics did not differ when recorded from HMs in the two
regions studied (Fig. 7B,C). For
GABAergic mIPSCs recorded in the presence of pentobarbital, the average
decay time was 66.1 ± 11.1 msec in the ventrolateral region and
67.9 ± 9.9 msec in the dorsal region (Fig. 7B,
left panel) (mean ± SEM, p > 0.1). Shown in Figure 7B (right panel) is
the averaged cumulative probability histogram of decay times recorded
from HMs in the two regions. The average decay time of GABA mIPSCs
recorded in the absence of pentobarbital was 19.0 ± 3.8 msec in
the ventrolateral region and 20.2 ± 1.1 msec in the dorsal region
(n = 6), and these also did not differ significantly
(mean ± SEM; p > 0.1). Additionally, the
amplitude and rise time of the pure GABAergic mIPSCs recorded in both
conditions (with and without pentobarbital) did not differ depending on
region (data not shown).
Similarly, the decay times of isolated glycinergic mIPSCs did not
significantly differ depending on region. In the presence of
pentobarbital, the average decay time was 10.0 ± 0.2 msec
(n = 3) in the ventrolateral region and 9.8 ± 0.4 msec (n = 3) in the dorsal region (Fig. 7C,
left panel) (mean ± SEM; p > 0.1). Shown in Figure 7C (right panel) is
the averaged cumulative probability histogram of decay times recorded
from HMs in the two regions. Additionally, the amplitude and rise time
data from the two regions did not differ significantly (data not shown).
Response amplitude to focal application of glycine and GABA depends
on location of HMs
To further test whether the density of glycine and
GABAA receptors present on juvenile HMs could
contribute to differences in the responses, we excised outside-out
somal patches from HMs located in either the ventrolateral or dorsal
region of the hypoglossal nucleus. For comparison, patches in the same
slices were excised from neurons in the dorsal motor nucleus of the
vagus, because the dorsal motor nucleus of the vagus exhibits high
levels of GABAA receptor
1 staining and low
levels of glycine receptor
1 staining (Figs. 1B,
2B). After excision, we focally applied glycine and
GABA in succession to each of the patches for 3 sec via a double-barrel
puffer pipette. To minimize variability, the puffer pipette was
visualized and kept secure in one location so that multiple patches
from a single slice could be aligned similarly with the puffer pipette.
The peak amplitudes of the glycinergic and GABAergic currents were
measured for each patch within a given slice. Data were normalized by
dividing the peak GABAergic current by the peak glycinergic current for
each patch. Data from a single slice are shown in Figure
8. Traces of data from different patches
are shown in Figure 8A. In patches from the dorsal
region, the GABAergic current peak amplitude was on average
approximately three-fourths of the glycinergic current peak amplitude,
whereas in the ventrolateral region the GABAergic current peak
amplitude was more than twice as large as the glycinergic current peak
amplitude (Fig. 8B). In patches from all three slices
studied, the ratio of the GABAergic current peak amplitude to the
glycinergic peak amplitude was always significantly greater in the
ventrolateral region when compared with the dorsal region
(p < 0.005). In the dorsal motor nucleus of
vagus, where there are high levels of GABAA
receptor staining and very low levels of glycine receptor staining, the
GABAergic current peak amplitude was on average almost six times larger than the glycinergic current peak amplitude across all slices studied
(data not shown).

View larger version (18K):
[in this window]
[in a new window]
|
Figure 8.
The response to focal application of
glycine (200 µM) and GABA (200 µM) onto
excised outside-out patches depends on location within the hypoglossal
nucleus of juvenile rats. The ratio of GABAergic/glycinergic peak
current amplitude is larger in patches from ventrolateral HMs as
compared with patches from dorsal HMs. A, For patches
from the dorsal region (n = 3), the peak amplitudes
of the GABAergic current were slightly smaller than the amplitude of
the glycinergic currents. However, in patches from the ventrolateral
region (n = 3), the GABAergic current was on
average ~2.3 times as large. Data shown are from a P11 rat. These
data are summarized in the bar graph in
B. In all three slices studied, the peak amplitude ratio
of the GABAergic/glycinergic current was always greater in patches from
ventrolateral HMs, when compared with ratios from the dorsal HMs.
|
|
Cotransmission of glycine and GABA to HMs in different regions of
the hypoglossal nucleus of juvenile rats
After determining that the level of GABAA
receptor
1 subunit labeling was related to the kinetic properties of
mIPSCs, we tested whether co-release of glycine and GABA could be
measured in both the ventrolateral and dorsal region of the hypoglossal nucleus. Previous work from our laboratory has demonstrated
cotransmission to HMs in neonatal (P1-5) animals (O'Brien and Berger,
1999
). The current study is focused on the juvenile age group. The
results above demonstrated that at this age GABAA
receptor
1 subunit and GABA neurotransmitter labeling appeared to be
mismatched. We studied whether this mismatch of receptor and
neurotransmitter affected measurements of co-release to HMs. If GABA
and glycine were co-released from single vesicles stored in presynaptic
terminals and both GABAergic and glycinergic receptors were present at
a single synapse, we would predict that mIPSCs should have both a fast
decaying glycinergic component and a slow decaying GABAergic component.
To investigate the degree to which cotransmission occurs in different
regions of the nucleus, we recorded mIPSCs in the presence of TTX (1 µM), DNQX (20 µM), and AP5 (25 µM). Using pentobarbital (25 µM) to slow
the GABAergic mIPSC decay times, we first recorded pure GABAergic and
glycinergic mIPSCs in isolation. For the isolated GABAergic and
glycinergic events, histogram distributions containing equal numbers
(2000) of GABAergic and glycinergic event decay times from different
cells were normalized. Data were normalized by dividing each histogram
bin by the total number of GABAergic and glycinergic events (4000 events). The GABAergic and glycinergic data were each fitted with a
single Gaussian (representing 50% GABAergic mIPSCs and 50%
glycinergic mIPSCs) for comparison with mixed mIPSCs recorded in either
the dorsal or ventrolateral region (Fig.
9A1). Also shown in Figure
9A2 are single traces showing pure GABAergic and glycinergic
mIPSCs. These traces show the short-duration rapidly decaying
glycinergic mIPSCs versus the longer-lasting slowly decaying GABAergic
mIPSCs.

View larger version (30K):
[in this window]
[in a new window]
|
Figure 9.
In juvenile HMs, dual component mIPSCs recorded in
HMs from the dorsal and ventrolateral regions of the nucleus.
A1, Normalized histogram distributions of the decay
times for pure GABAergic (black bars) and pure
glycinergic mIPSCs (white bars) recorded in isolation in
the presence of pentobarbital. For comparison, each distribution,
composed of equal numbers of events, is fitted with a Gaussian.
A2, Raw data of pure GABAergic and glycinergic mIPSCs.
B1, C1, Mixed GABAergic and glycinergic
mIPSCs recorded in the presence of pentobarbital in an HM from the
ventrolateral region (B1) and an HM from the dorsal
region (C1) of the hypoglossal nucleus. Superimposed on
each graph is the Gaussian fit of the pure GABAergic and glycinergic
events. B2, C2, Dual-component mIPSCs
having both fast and slow decaying components are present in the raw
traces of HMs from both regions (asterisks). The
calibration shown in C2 also applies to
A2 and B2.
|
|
We then plotted distributions of the decay times of mixed mIPSCs from
HMs in either the ventrolateral or dorsal region (Fig. 9, B1
and C1, respectively). The mIPSC decay times distributions from these two juvenile HMs were statistically different
(Kolmogorov-Smirnov test; p < 0.05). We superimposed
the Gaussian fits of pure GABAergic and glycinergic mIPSCs on each
histogram. In the ventrolateral region the frequency distribution of
decay times clearly differed from distributions of the pure GABAergic
and glycinergic mIPSCs (Fig. 9B1). The distribution shown in
Figure 9B1 indicates that there were a large number of
events with decay times from ~20 to 30 msec that were not present in
the predicted pure GABAergic or pure glycinergic distributions. These
results suggest that both GABAA and glycine
receptors contributed to the decay times of many single mIPSCs. In the
dorsal region, decay times of mIPSCs had a distribution more similar to
the pure GABAergic and pure glycinergic Gaussians (Fig.
9C1). However, in both cases when we examined the raw data
traces we were able to detect dual component mIPSCs (Fig.
9B2,C2, asterisks). This result
suggests that dual-component mIPSCs, caused by co-release of GABA and
glycine from single synaptic vesicles, occurred in both ventrolateral
and dorsal HMs. However, detection of such events from HMs of the
dorsal region via distributions of decay times was more difficult
because the GABAergic component in these dual-component events was
often very small when compared with the glycinergic component of the mIPSCs.
 |
DISCUSSION |
Developmental changes in inhibitory synaptic transmission
Our immunohistochemical studies demonstrate that there are changes
in both the GABAA and glycine receptor subunit
staining throughout development. We found that labeling of
GABAA and glycine
1 subunits, normally present
in adult HMs (Fritschy and Mohler, 1995
; Singer et al., 1998
), was weak
in the neonatal hypoglossal nucleus. Nevertheless, in a previous study
we recorded glycinergic and GABAergic synaptic responses in neonates
(O'Brien and Berger, 1999
). These data suggest that both
GABAA and glycine receptors are present on
neonatal HMs; however, these receptors do not contain the respective
1 subunits. Thus in the neonate, the glycine receptor-mediated responses may arise from glycine receptors expressing
2 subunits that are found (Singer et al., 1998
). The
GABAA receptor-mediated events may be caused by
GABAA receptors expressing
2 subunits (Donato
and Nistri, 2000
).
We recorded GABAA receptor-meditated mIPSCs
throughout the juvenile hypoglossal nucleus and found that the decay
times of GABAA receptor-mediated mIPSCs became
faster with postnatal development by comparing the decay times of
GABAergic responses from this study with the neonatal decay times from
our previous study (O'Brien and Berger, 1999
). Other reports have
shown that changes in GABAergic mIPSCs decay kinetics reflect changes
in receptor desensitization rates (Jones and Westbrook, 1996
). In
expression systems, changes in desensitization and deactivation are
correlated with expression of different subunits (Verdoorn et al.,
1990
; Gingrich et al., 1995
; Tia et al., 1996
), suggesting that changes
in GABAA
1 subunit expression in the nucleus
with postnatal development could influence response kinetics.
We recorded glycine receptor-mediated mIPSCs and found that the
developmental decrease in decay times of GABAergic responses is
paralleled by a decrease in the decay times of glycinergic responses
(O'Brien and Berger, 1999
). Previous work from our laboratory has
demonstrated that changes in
subunit expression lead to functional
changes in the electrophysiological properties of the glycinergic
currents (Singer et al., 1998
). In HMs the glycinergic mIPSC decay time
shortened with development because of changes in channel deactivation
rate. These changes correlated with a decrease in
2 subunit
expression and an increase in
1. In HMs the faster kinetics of
inhibitory responses with development, as compared with the neonates,
may be important for timing of motor output.
Also, throughout the adult (P28-30) nucleus,
GABAA receptor
1 subunit labeling was weaker,
whereas glycine receptor
1 subunit labeling was uniform and dense.
These data suggest that in adult HMs, glycinergic synaptic transmission
is predominant over GABAergic synaptic transmission. It is possible
that GABAA receptors are present on the dendrites
of hypoglossal motoneurons that project beyond the hypoglossal nucleus,
accounting for measurable GABAergic responses in adult rabbit and cat
(Altmann et al., 1972
; Takata and Ogata, 1980
). However, in other
systems inhibited both by GABA and glycine in neonatal neurons, the
contribution of GABA decreases during development. In the lateral
superior olive of the gerbil auditory system, there is a shift from
GABAergic to glycinergic synaptic transmission (Kotak et al., 1998
).
The decrease in GABAergic synaptic transmission is accompanied by a
decrease in the GABAA receptor
2/3 subunit labeling.
Functional differences between GABAergic and glycinergic
synaptic transmission
We compared the kinetics of GABAergic and glycinergic mIPSCs
in juvenile HMs and found that the GABAA
receptor-mediated currents decayed significantly slower than glycine
responses (even in the absence of pentobarbital). Shunting inhibition
arises from an increase in membrane conductance. Overlapping of slower
synaptic events, or continuous activation of
GABAA receptors, has been demonstrated in
cerebellar granule, hippocampal, and cortical neurons (Staley and Mody,
1992
; Brickley et al., 1996
; Salin and Prince, 1996
). As demonstrated
in the hippocampus, shunting inhibition via GABA may be important to
preferentially block slower NMDA excitatory currents as compared with
faster non-NMDA excitatory currents. (Staley and Mody, 1992
). Because
the reversal potential for chloride is similar to the resting potential
of juvenile HMs (Singer et al., 1998
), both GABAA
and glycine receptor activation would result in shunting inhibition,
with slower GABAA receptor-mediated events
producing a longer duration shunt.
Differential distribution of GABAA
1 subunit in the
hypoglossal nucleus
In juvenile HMs we found that the GABAA
receptor
1 subunit is differentially distributed within the
hypoglossal nucleus. Labeling of the GABAA
receptor
1 subunit was greatest in the ventrolateral region of the
nucleus and modest in the dorsal region. This differential distribution
of GABAA receptor
1 subunit labeling is absent
in adult HMs. In contrast, the glycine receptor
1 subunit distribution was uniform throughout the nucleus. In juvenile HMs, mIPSCs from the ventrolateral region had slower decay kinetics than
mIPSCs from the dorsal region. Outside-out patch current recordings
revealed that the ratio of GABAergic to glycinergic currents was larger
in the ventrolateral region as compared with the dorsal region. These
results suggest that mIPSCs recorded from ventrolateral HMs have larger
GABAA receptor-mediated components.
It is possible that in the dorsal region of the nucleus there were
GABAA receptor subunits expressed that we were
unable to detect with the specific antibody used. However, the
properties of pure GABAergic mIPSCs recorded from different regions of
the hypoglossal nucleus did not differ. Therefore, we believe that the
differences observed in the mixed mIPSCs and outside-out patch responses from different regions of the nucleus were caused by variations in the number of GABAA
receptor-mediated synapses in various regions rather than differences
in subunit composition.
What is the functional significance of having different subpopulations
of motoneurons with respect to the distribution of
1 subunits of the
GABAA and glycine receptors? The tongue is a
complex muscle made up of eight different muscle groups (Lowe, 1980
).
The hypoglossal nucleus is somatotopically organized. The lateral
branch of the hypoglossal nerve contains axons that arise from HMs
located in the dorsal portion of the motor nucleus and innervates
extrinsic retractor tongue muscles (Dobbins and Feldman, 1995
). The
medial branch of the hypoglossal nerve has axons from HMs that have
cell bodies located in the ventral portion of the hypoglossal nucleus,
and the medial branch of the hypoglossal nerve innervates the
main protruder tongue muscle (Dobbins and Feldman, 1995
; McClung and
Goldberg, 1999
). Thus motoneurons projecting to the same muscle are
located within distinct regions of the hypoglossal nucleus. Muscle
compartmentalization of the hypoglossal motor nucleus is found in
newborn animals (1-2 d old) and remains present throughout development
(Sokoloff, 1993
). Differential sensitivity to GABA and glycine of
different HMs that innervate different tongue muscles may be important
for normal function of these tongue muscles.
Co-release of glycine and GABA onto HMs
We have demonstrated that glycine and GABA are co-released onto
both neonatal and juvenile HMs. In specific areas of the juvenile hypoglossal motor nucleus, immunohistochemical studies revealed that
glycine receptor
1 subunit labeling remained dense and uniform, whereas GABAA receptor
1 subunit was weak.
These data suggest that in certain regions of the juvenile hypoglossal
nucleus, glycine is the predominant inhibitory neurotransmitter.
However, GABA neurotransmitter labeling was uniformly present in the
juvenile hypoglossal nucleus. In both the dorsal and ventrolateral
regions of the juvenile nucleus, where GABAA
receptor labeling was different, dual component mIPSCs were recorded.
These data suggest that GABA is co-released with glycine throughout the
juvenile hypoglossal nucleus.
What is the function of GABA and glycine co-release? At excitatory
synapses, GABA has been shown to act on presynaptic
GABAB receptors, decreasing neurotransmitter
release (Bowery et al., 1980
). A similar effect of
GABAB receptor activation has also been shown to
decrease GABA and glycine receptor-mediated synaptic transmission in
several systems (Doze et al., 1995
; Khazipov et al., 1995
; Kotak et
al., 1998
; Lim et al., 2000
). Anatomical studies have shown that
GABAB receptors are present in the hypoglossal nucleus (Margeta-Mitrovic et al., 1999
), and there is physiological evidence that activation of GABAB receptors can
influence responses of HMs. Work by Okabe et al. (1994)
suggests that
GABAB receptors located within the hypoglossal
nucleus may influence the hypoglossal nerve activity in
vivo. It is possible that co-release of GABA at glycinergic
synapses may activate presynaptic GABAB receptors in adult and juvenile HMs, located on these or nearby synaptic terminals, thereby reducing GABAA and glycine
receptor-mediated inhibitory neurotransmission.
 |
FOOTNOTES |
Received June 7, 2001; revised Aug. 17, 2001; accepted Aug. 22, 2001.
J.A.O. was supported by National Institutes of Health (NIH) Training
Grant 5T32GM07108. This research was supported by NIH Grants HL-49657
and NS-14857 to A.J.B. We thank Dr. David Pow (University of
Queensland, Australia) for the gift of the GABA and glycine
neurotransmitter antibodies courtesy of Dr. Anita Hendrickson
(University of Washington). We also thank Paulette Brunner for her
assistance with the confocal microscopy. We are grateful to Mark
Mazurek, Erika Eggers, and Rebecca Lim for reading and commenting on
this manuscript and Dr. William Satterthwaite and Phan Huynh for
technical assistance.
Correspondence should be addressed to Dr. Albert J. Berger, Department
of Physiology and Biophysics, University of Washington, Box 357290, Seattle, WA 98195-7290. E-mail:
berger{at}u.washington.edu
 |
REFERENCES |
-
Altmann H,
Cherubini E,
Sonnhof U
(1972)
Differential strength of action of glycine and GABA in hypoglossus nucleus.
Pflügers Arch
331:90-94[ISI][Medline].
-
Bowery NG,
Hill DR,
Hudson AL,
Doble A,
Middlemiss DN,
Shaw J,
Turnbull M
(1980)
(
)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.
Nature
283:92-94[Medline]. -
Brickley SG,
Cull-Candy SG,
Farrant M
(1996)
Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors.
J Physiol (Lond)
497:753-759[ISI][Medline].
-
Cochran SL
(1993)
Algorithms for detection and measurement of spontaneous events.
J Neurosci Methods
50:105-121[ISI][Medline].
-
Crawford GD,
Correa L,
Salvaterra PM
(1982)
Interaction of monoclonal antibodies with mammalian choline acetyltransferase.
Proc Natl Acad Sci USA
79:7031-7035[Abstract/Free Full Text].
-
Dobbins EG,
Feldman JL
(1995)
Differential innervation of protruder and retractor muscles of the tongue in rat.
J Comp Neurol
357:376-394[ISI][Medline].
-
Donato R,
Nistri A
(2000)
Relative contribution by GABA or glycine to Cl(
)-mediated synaptic transmission on rat hypoglossal motoneurons in vitro.
J Neurophysiol
84:2715-2724[Abstract/Free Full Text]. -
Doze VA,
Cohen GA,
Madison DV
(1995)
Calcium channel involvement in GABAB receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus.
J Neurophysiol
74:43-53[Abstract/Free Full Text].
-
Fritschy JM,
Mohler H
(1995)
GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits.
J Comp Neurol
359:154-194[ISI][Medline].
-
Fritschy JM,
Paysan J,
Enna A,
Mohler H
(1994)
Switch in the expression of rat GABAA-receptor subtypes during postnatal development: an immunohistochemical study.
J Neurosci
14:5302-5324[Abstract].
-
Gao BX,
Ziskind-Conhaim L
(1995)
Development of glycine- and GABA-gated currents in rat spinal motoneurons.
J Neurophysiol
74:113-121[Abstract/Free Full Text].
-
Gingrich KJ,
Roberts WA,
Kass RS
(1995)
Dependence of the GABAA receptor gating kinetics on the alpha-subunit isoform: implications for structure-function relations and synaptic transmission.
J Physiol (Lond)
489:529-543[ISI][Medline].
-
Isaacson JS,
Walmsley B
(1995)
Counting quanta: direct measurements of transmitter release at a central synapse.
Neuron
15:875-884[ISI][Medline].
-
Jonas P,
Bischofberger J,
Sandkuhler J
(1998)
Corelease of two fast neurotransmitters at a central synapse.
Science
281:419-424[Abstract/Free Full Text].
-
Jones MV,
Westbrook GL
(1996)
The impact of receptor desensitization on fast synaptic transmission.
Trends Neurosci
19:96-101[ISI][Medline].
-
Katz B
(1969)
In: The release of neural transmitter substances. Liverpool: Liverpool UP.
-
Khazipov R,
Congar P,
Ben Ari Y
(1995)
Hippocampal CA1 lacunosum-moleculare interneurons: modulation of monosynaptic GABAergic IPSCs by presynaptic GABAB receptors.
J Neurophysiol
74:2126-2137[Abstract/Free Full Text].
-
Konrat G,
Halliday G,
Sullivan C,
Harper C
(1992)
Preliminary evidence suggesting delayed development in the hypoglossal and vagal nuclei of SIDS infants: a necropsy study.
J Child Neurol
7:44-49